INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Corporate insider
JL

Johnson Philip L

EVP & Chief Financial OfficerCIK 0002013156

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score19
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
JL
Johnson Philip LEVP & Chief Financial Officer
JAZZJazz Pharmaceuticals plc
Tax withholding
F$795K
3,343 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Jazz Pharmaceuticals plcEVP & Chief Financial Officer · Mar 2, 2026
15
JL
Johnson Philip LEVP & Chief Financial Officer
JAZZJazz Pharmaceuticals plc
Tax withholding
F
$493K
2,615 sh
Mar 5, 2026
Mar 9, 2026
traded Mar 5, 2026
+4d
SEC FORM 4

Evidence

17
JL
Johnson Philip LEVP & Chief Financial Officer
JAZZJazz Pharmaceuticals plc
Grant or award
A—
11.9K sh
Feb 26, 2026Mar 2, 2026
traded Feb 26, 2026
+4dSEC FORM 4

Evidence